Multileaf collimation cardiac shielding in breast radiotherapy: Cardiac doses are reduced, but at what cost?

Clinical Oncology

Volumn 25, Issue 12, 2013, Pages 690-696

  Bartlett, F R ^a   Yarnold, J R ^a,b   Donovan, E M ^a   Evans, P M ^a,c   Locke, I ^a   Kirby, A M ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Breast cancer; Cardiac dose; Cardiac shielding; Radiotherapy; Target tissue coverage

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER RECURRENCE; DECISION MAKING; FEMALE; HEART; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MULTILEAF COLLIMATOR; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION PROTECTION; RETROSPECTIVE STUDY; TARGET ORGAN; THORAX WALL; TREATMENT PLANNING;

BREAST CANCER; CARDIAC DOSE; CARDIAC SHIELDING; RADIOTHERAPY; TARGET TISSUE COVERAGE;

BREAST NEOPLASMS; FEMALE; HEART; HUMANS; MASTECTOMY, SEGMENTAL; RADIATION INJURIES; RADIATION PROTECTION; RADIOGRAPHY, INTERVENTIONAL; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, ADJUVANT; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84887025887     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2013.09.002     Document Type: Article

References (39)

1. Darby S., McGale P., Correa C., et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 2011, 378:1707-1716.
2. Taylor C.W., Brønnum D., Darby S.C., et al. Cardiac dose estimates from Danish and Swedish breast cancer radiotherapy during 1977-2001. Radiother Oncol 2011, 100:176-183.
3. McGale P., Darby S.C., Hall P., et al. Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden. Radiother Oncol 2011, 100:167-175.
4. Darby S.C., McGale P., Taylor C.W., Peto R. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol 2005, 6:557-565.
5. Taylor C.W., Nisbet A., McGale P., Darby S.C. Cardiac exposures in breast cancer radiotherapy: 1950s-1990s. Int J Radiat Oncol Biol Phys 2007, 69:1484-1495.
6. Darby S.C., Ewertz M., McGale P., et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. NEngl J Med 2013, 368:987-998.
7. van der Laan H.P., Hurkmans C.W., Kuten A., Westenberg H.A. Current technological clinical practice in breast radiotherapy; results of a survey in EORTC-Radiation Oncology Group affiliated institutions. Radiother Oncol 2010, 94:280-285.
8. Coles C.E., Wilson C.B., Cumming J., et al. Titanium clip placement to allow accurate tumour bed localisation following breast conserving surgery - audit on behalf of the IMPORT Trial Management Group. Eur J Surg Oncol 2009, 35:578-582.
9. International Commission on Radiation Units and Measurements.ICRU Report 62 Prescribing, recording and reporting photon beam therapy (Supplement to ICRU Report 50) 1999, ICRU, Bethesda, MD.
10. Yarnold J., Coles C. Randomised trial testing dose escalated intensity modulated radiotherapy for women treated by breast conservation surgery and appropriate systemic therapy for early breast cancer 2009, 1-26. On behalf of the IMPORT HIGH Trial Management Group: Intensity Modulated and Partial Organ RadioTherapy, Planning Pack, version 1, Institute of Cancer Research, Sutton, Surrey, UK, Available at:. http://rttrialsqa.dnsalias.org/IMPORT%20HIGH_files/4%5B1%5D.2%20Planning%20Pack%20IMPORT%20HIGH%20final%20version%201.0%2020090330.pdf.
11. Taylor C.W., Povall J.M., McGale P., et al. Cardiac dose from tangential breast cancer radiotherapy in the year 2006. Int J Radiat Oncol Biol Phys 2008, 72:501-507.
12. Scrimger R.A., Tome W.A., Olivera G.H., Reckwerdt P.J., Mehta M.P., Fowler J.F. Reduction in radiation dose to lung and other normal tissues using helical tomotherapy to treat lung cancer, in comparison to conventional field arrangements. Am J Clin Oncol 2003, 26:70-78.
13. Schultz-Hector S., Sund M., Thames H.D. Fractionation response and repair kinetics of radiation-induced heart failure in the rat. Radiother Oncol 1992, 23:33-40.
14. Lauk S., Ruth S., Trott K.R. The effects of dose-fractionation on radiation-induced heart disease in rats. Radiother Oncol 1987, 8:363-367.
15. Kirby A.M., Evans P.M., Donovan E.M., Convery H.M., Haviland J.S., Yarnold J.R. Prone versus supine positioning for whole and partial-breast radiotherapy: a comparison of non-target tissue dosimetry. Radiother Oncol 2010, 96:178-184.
16. Elkhuizen P.H.M., van de Vijver P.D., Hermans D.J., Zonderland H.M., van de Velde P.D.C.J.H., Leer P.D.J.-W.H. Local recurrence after breast-conserving therapy for invasive breast cancer: high incidence in young patients and association with poor survival. Int J Radiat Oncol Biol Phys 1998, 40:859-867.
17. Horst K.C., Smitt M.C., Goffinet D.R., Carlson R.W. Predictors of local recurrence after breast-conservation therapy. Clin Breast Cancer 2005, 5:425-438.
18. Hunt K.K., Ballman K.V., McCall L.M., et al. Factors associated with local-regional recurrence after a negative sentinel node dissection: results of the ACOSOG Z0010 Trial. Ann Surg 2012, 256:428-436.
19. Jones H.A., Antonini N., Hart A.A., et al. Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial. JClin Oncol 2009, 27:4939-4947.
20. Kontos M., Allen D.S., Agbaje O.F., Hamed H., Fentiman I.S. Factors influencing loco-regional relapse in older breast cancer patients treated with tumour resection and tamoxifen. Eur J Surg Oncol 2011, 37:1051-1058.
21. Werkhoven E., Hart G., Tinteren H., et al. Nomogram to predict ipsilateral breast relapse based on pathology review from the EORTC 22881-10882 boost versus no boost trial. Radiother Oncol 2011, 100:101-107.
22. Price P., Walsh G., McKinna A.J., Ashley S., Yarnold J.R. Patterns of breast relapse after local excision ± radiotherapy for early stage breast cancer. Radiother Oncol 1988, 13:53-60.
23. Fowble B., Solin L.J., Schultz D.J., Rubenstein J., Goodman R.L. Breast recurrence following conservative surgery and radiation: patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment. Int J Radiat Oncol Biol Phys 1990, 19:833-842.
24. Johnson J.E., Page D.L., Winfield A.C., Reynolds V.H., Sawyers J.L. Recurrent mammary carcinoma after local excision. A segmental problem. Cancer 1995, 75:1612-1618.
25. Bartelink H., Horiot J.C., Poortmans P.M., et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. JClin Oncol 2007, 25:3259-3265.
26. Bentzen S.M., Agrawal R.K., Aird E.G., et al. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol 2008, 9:331-341.
27. Hancock S.L., Donaldson S.S., Hoppe R.T. Cardiac disease following treatment of Hodgkin's disease in children and adolescents. JClin Oncol 1993, 11:1208-1215.
28. Adams M.J., Lipsitz S.R., Colan S.D., et al. Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. JClin Oncol 2004, 22:3139-3148.
29. Hancock S.L., Tucker M.A., Hoppe R.T. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA 1993, 270:1949-1955.
30. Harris E.E., Correa C., Hwang W.T., et al. Late cardiac mortality and morbidity in early-stage breast cancer patients after breast-conservation treatment. JClin Oncol 2006, 24:4100-4106.
31. Hull M.C., Morris C.G., Pepine C.J., Mendenhall N.P. Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy. JAMA 2003, 290:2831-2837.
32. Hooning M.J., Botma A., Aleman B.M., et al. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. JNatl Cancer Inst 2007, 99:365-375.
33. Appelt A.L., Vogelius I.R., Bentzen S.M. Modern hypofractionation schedules for tangential whole breast irradiation decrease the fraction size-corrected dose to the heart. Clin Oncol 2013, 25:147-152.
34. Kirby A.M., Evans P.M., Helyer S.J., Donovan E.M., Convery H.M., Yarnold J.R. Arandomised trial of supine versus prone breast radiotherapy (SuPr study): comparing set-up errors and respiratory motion. Radiother Oncol 2011, 100:221-226.
35. Pedersen A.N., Korreman S., Nyström H., Specht L. Breathing adapted radiotherapy of breast cancer: reduction of cardiac and pulmonary doses using voluntary inspiration breath-hold. Radiother Oncol 2004, 72:53-60.
36. Korreman S.S., Pedersen A.N., Nottrup T.J., Specht L., Nystrom H. Breathing adapted radiotherapy for breast cancer: comparison of free breathing gating with the breath-hold technique. Radiother Oncol 2005, 76:311-318.
37. Sixel K.E., Aznar M.C., Ung Y.C. Deep inspiration breath hold to reduce irradiated heart volume in breast cancer patients. Int J Radiat Oncol Biol Phys 2001, 49:199-204.
38. Coles C.E., Brunt A.M., Wheatley D., Mukesh M.B., Yarnold J.R. Breast radiotherapy: less is more?. Clin Oncol 2013, 25:127-134.
39. Prescott R.J., Kunkler I.H., Williams L.J., et al. Arandomised controlled trial of postoperative radiotherapy following breast-conserving surgery in a minimum-risk older population. The PRIME trial. Health Technol Assess 2007, 11:1-149. iii-iv.